Table 1.
Phase one: Intervention development (n = 13) | Phase two: Feasibility testing (n = 20) | |
---|---|---|
Participant type | ||
Patient | 11 | 16 |
Patient representative | 2 | 4 |
Gender | ||
Female | 9 | 8 |
Male | 4 | 12 |
Department | ||
Acute stroke | 3 | 7 |
Orthopaedic | 8 | 11 |
Surgical oncology | 2 | 2 |